skip to content
Therapeutic nuclear medicine Preview this item
ClosePreview this item

Therapeutic nuclear medicine

Author: Richard P Baum
Publisher: Heidelberg : Springer, 2014.
Series: Medical radiology (Series)
Edition/Format:   eBook : Document : EnglishView all editions and formats
The recent revolution in molecular biology offers exciting new opportunities for targeted radionuclide therapy. The selective irradiation of tumor cells through molecular biological mechanisms is now permitting the radiopharmaceutical control of tumors that are unresectable and unresponsive to either chemotherapy or conventional radiotherapy. In this up-to-date, comprehensive book, world-renowned experts discuss the  Read more...
You are not connected to the University of Cape Town Libraries network. Access to online content and services may require you to authenticate with your library. Off-campus access
Getting this item's online copy... Getting this item's online copy...

Find a copy in the library

Getting this item's location and availability... Getting this item's location and availability...


Find it in libraries globally
Worldwide libraries own this item


Genre/Form: Electronic books
Additional Physical Format: Print version:
Therapeutic nuclear medicine
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Richard P Baum
ISBN: 9783540367192 3540367195 3540367187 9783540367185
OCLC Number: 888155213
Notes: Includes index.
Description: 1 online resource.
Contents: A Historical Perspective on the Use of Radionuclides for Therapy --
Therapeutic Radionuclides: Production, Physical Characteristics, and Applications --
Rhenium-188 Generator-Based Radiopharmaceuticals for Therapy --
Generator-Based Radiopharmaceuticals for PET Dosimetry Before, During, and After Endoradiotherapy --
Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy --
Peptides for Nuclear Medicine Therapy: Chemical Properties and Production --
Antibodies for Nuclear Medicine Therapy --
Selective High Affinity Ligands: A New Class of Targeting Agents for Cancer Imaging and Therapy --
Inorganic Radionuclides for Nuclear Medicine Therapy --
Pharma Considerations for Timely Development of Therapeutic Radiopharmaceuticals --
Economic and Industrial Considerations for Marketing of Therapeutic Radiopharmaceuticals --
Radioimmunotherapy of Brain Tumors --
Radiopeptide Therapy of Brain Tumors --
Intracavitary Use of Radionuclides and Treatment of Meningiomas --
Radio-Tympano-Sinu-Orthesis as a Treatment Option in Chronic Otitis Media and Paranasal Mucositis --
Sodium Iodide Symporter in Thyroid Carcinoma --
Gene Expression Analysis by DNA Microarray in Papillary and Follicular Differentiated Thyroid Cancer --
Ablation Therapy with Radioiodine in Adults and Children with Differentiated Thyroid Cancer --
Redifferentiation Therapy in Thyroid Cancer --
Maximal Safe Dose Method of I-131 in the Management of Recurrent/Metastatic Differentiated Thyroid Carcinoma --
Therapeutic Strategy of Papillary Microcarcinoma of the Thyroid Gland: A Nuclear Medicine Perspective --
UICC Classifications 1997, 2002 and 2009: What is the Impact on Thyroid Cancer Management? --
Radioiodine Remnant Ablation: A Critical Review --
Follow-up of Thyroid Cancer Patients and Treatment of Distant Metastases --
Medullary Thyroid Carcinoma --
Treatment of Progressive Dedifferentiated and Medullary Thyroid Cancer with Radiolabeled Somatostatin Analogs --
Radioiodine Therapy of Hyperthyroidism (Toxic Goiter, Hyperfunctioning Nodule) and Non-Toxic Goiter: Procedures and Guidelines --
Radioiodine Therapy of Hyperthyroidism in Graves' Disease --
Radioembolization: Concepts and Procedures --
Radioembolization: Clinical Results Hepatocellular Carcinoma --
Radioembolization (Yttrium-90 Microspheres) for Metastatic Hepatic Malignancies --
Rhenium-188 Lipiodol for the Treatment of Hepatocellular Carcinoma (HCC) --
New Approaches: Combined Local and Multimodal Strategies in the Treatment of Complex Neuroendocrine Liver Metastases --
Radiolabelled Bisphosphonates for Bone Pain Palliation --
Radionuclide Therapy of Bone Metastases Using Rhenium-188 Hydroxyethylidene Diphosphonate --
Treatment of Osteoblastic Skeletal Metastases by the Alpha-Emitting Bone-Seeker Radium-223 --
Radionuclide Therapy of Inflammatory Joint Diseases (Radiation Synovectomy, Radiosynoviorthesis) --
Radionuclide Therapy for Bleeding Joints in Hemophilia --
Non-Hodgkin Lymphoma: Radioimmunotherapy Using Iodine-131 Labeled Murine Anti-CD20 Antibodies (131 I-Tositumomab and Tositumomab, "Bexxar"). Treatment of Lymphoma with 131 I-Chimeric Monoclonal Antibodies --
Non-Hodgkin's Lymphoma High Dose Therapy --
Yttrium-90 Labelled Anti-CD20 Radioimmunotherapy with Stem Cells Support --
Fractionated Radioimmunotherapy of Non-Hodgkin Lymphoma with 90-Y-Labeled Anti-CD22 Antibody, Epratuzumab Tetraxetan --
Targeted Alpha Particle Therapy of Peritoneal Carcinomas --
I-131 Meta Iodobenzylguanidine Therapy --
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors Expressing Somatostatin Receptors --
Radioimmunotherapy of Tumors: Pretargeting with Bispecific Antibodies --
Targeted Radionuclide Therapy of Prostate Cancer --
Radioimmunotherapy of Neuroblastoma --
Radioimmunotherapy in Metastatic Colorectal Cancer --
Radioimmunotherapy of Renal Cancer --
Myeloablative Radioimmunotherapy in Conditioning of Acute Leukemia, MDS, and Multiple Myeloma Prior to Hematological Stem Cell Transplantation --
Endovascular Brachytherapy to Prevent Restenosis After Percutaneous Coronary Intervention --
Locoregional Radionuclide Therapy of Primary and Metastatic Cancers --
Radionuclide Therapy for Skin Malignancies --
Epidermal Radionuclide Therapy: Dermatological High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinoma --
Patient-Specific Dosimetry, Radiobiology, and the Previously-Treated Patient --
Nuclear Medicine Dose Assessment --
Monte Carlo Methods in Nuclear Medicine --
Dosimetry for Peptide Receptor Radionuclide Therapy --
Comparison Between ß -Emitting Isotopes and [a] -Emitters Regarding Their Effects on Cancer Cells --
Hormesis by Low Dose Radiation Effects: Low-Dose Cancer Risk Modeling Must Recognize Up-Regulation of Protection --
Animal Models for Developing Radiopharmaceuticals for Therapy --
Dosimetry in Accidental Radiation Exposure --
Potential Impact of Radiation Biology in Radiation Protection in Nuclear Medicine and Corresponding Regulatory Issues --
Radiation Protection of Staff and Public --
Effects of Music on the Psyche of Neuroendocrine Tumour Patients Undergoing Peptide Receptor Radionuclide Therapy --
The Use of Dosimetry in the Planning of Patient Therapy --
PET for Radiotherapy Planning --
Hypoxia Imaging for Radiation Therapy Planning --
Chemotherapy Combined with Radionuclide Therapy --
Role of Surgery in a Multidisciplinary Approach --
PET for Measuring Therapy Response After Radionuclide Therapy --
Developing Probes for Molecular Imaging.
Series Title: Medical radiology (Series)
Responsibility: Richard P. Baum, editor.


This book discusses basic principles of radionuclide therapy, explores available treatments, explains the regulatory requirements, and examines future developments. It details the knowledge required  Read more...
Retrieving notes about this item Retrieving notes about this item


Editorial reviews

Publisher Synopsis

"The text can be considered an up to date encyclopaedia of therapeutic nuclear medicine in which it is possible to find almost all the information needed to work well in this field. Although research Read more...

User-contributed reviews


Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.